← BPA

The Endocrine Disruptor in Your Packaging

How bisphenol A disrupts hormones, why BPA-free plastics are not a safe substitute, and practical ways to reduce your daily exposure

BPA (bisphenol A) is a synthetic chemical that has been used since the 1960s to harden plastics and line metal food cans. It leaches from containers into food and drink, and biomonitoring studies find it in the urine of over 90% of people tested in the United States [4]. The problem is that BPA is a potent endocrine disruptor — it mimics estrogen at the cellular level, binding to hormone receptors and interfering with the body's signaling systems [1]. Associations have been found with metabolic disorders, reproductive problems, developmental effects in children, and cardiovascular disease. Switching to "BPA-free" products helps at the margins, but the most common replacements — bisphenol S (BPS) and bisphenol F (BPF) — appear to be equally hormone-disrupting [3].

How BPA Disrupts the Endocrine System

BPA's structure is similar enough to estradiol (the primary human estrogen) that it can bind to estrogen receptors (ER-alpha and ER-beta) throughout the body. At these receptors it acts as an agonist — triggering estrogenic responses — at concentrations found in typical human exposure. It also interferes with androgen (testosterone) signaling, acting as an anti-androgen, and disrupts thyroid hormone activity by competing with thyroid hormones for transport proteins [1].

The dose-response relationship for BPA does not follow the usual linear pattern assumed by traditional toxicology. Researchers have documented "non-monotonic" effects, meaning low doses can sometimes produce different or stronger effects than high doses — a phenomenon well-established in endocrinology (because hormones themselves work this way) but which makes standard risk assessments based on high-dose animal studies difficult to apply [2].

Where BPA Exposure Comes From

Canned food and drinks are the largest single dietary source. Epoxy resin linings in most canned goods contain BPA, and acidic foods (tomatoes, citrus) and heat accelerate leaching. Studies measuring BPA in canned tomato soup find concentrations that, when combined with typical consumption patterns, represent meaningful daily doses.

Polycarbonate plastics (the hard, clear plastic used in some reusable water bottles, food storage containers, and baby bottles) are made from BPA. These leach more BPA as they age, are scratched, or are exposed to heat — including dishwasher cycles and microwave use.

Thermal paper (receipts, airline tickets, some boarding passes) is coated with BPA as a color developer. Handling receipts — especially after using hand sanitizer, which significantly increases skin absorption — is a measurable exposure route. Cashiers who handle receipts throughout the day show elevated urinary BPA compared to controls [1].

Dental sealants and composites traditionally contained BPA or BPA-releasing compounds. Most modern dental materials have reduced or eliminated BPA, but it is worth asking your dentist about the materials they use.

Food packaging more broadly — the inner linings of cardboard food boxes, bottle caps, and some flexible food packaging — may contain BPA or its analogs.

Health Effects: What the Evidence Shows

A 2013 review by Rochester catalogued 91 human studies linking BPA exposure to adverse health outcomes. The most consistent associations are:

Metabolic disease: Higher urinary BPA correlates with increased risk of type 2 diabetes, obesity, and cardiovascular disease in cross-sectional studies. BPA appears to interfere with insulin signaling and pancreatic beta-cell function [1].

Reproductive effects: In women, higher BPA exposure is associated with PCOS, endometriosis, recurrent miscarriage, and reduced IVF success rates. In men, associations have been found with reduced sperm count, sperm DNA damage, and altered sex hormone levels [1].

Developmental and neurobehavioral effects: Prenatal BPA exposure has been associated with altered behavioral outcomes in children, including increased anxiety, hyperactivity, and aggression. The developing brain is particularly sensitive to endocrine disruption during windows of vulnerability in fetal and early childhood development [2].

Thyroid disruption: BPA competes with thyroid hormones for binding to transthyretin (a transport protein), potentially reducing circulating thyroid hormone levels. Thyroid disruption during fetal development has significant consequences for brain development [1].

A 2021 update by Vom Saal and Vandenberg — two of the leading BPA researchers — concluded that the accumulated evidence of harm is now overwhelming, and that regulatory standards based on older animal data have failed to account for the non-monotonic dose-response and the sensitivity of the developing organism [2].

The BPA-Free Problem

When BPA was restricted from baby bottles and sippy cups in the early 2010s (and subsequently in many other product categories), manufacturers replaced it with bisphenol S (BPS) and bisphenol F (BPF). These were considered safer because they were less studied. A 2015 systematic review by Rochester and Bolden changed that calculus substantially.

Examining 32 studies of BPS and BPF hormonal activity, the review found that both compounds are as hormonally active as BPA, producing estrogenic, anti-androgenic, and other hormone-disrupting effects across in vitro and animal studies at comparable concentrations [3]. BPS also appears to be more environmentally persistent than BPA. The "BPA-free" label, in short, provides false reassurance — it has substituted one bisphenol for another.

The broader issue is structural: the entire class of bisphenol chemicals shares a core molecular structure that confers estrogenic activity. True risk reduction requires reducing plastic contact with food and heat, not brand-label switching.

Practical Ways to Reduce Exposure

The largest reductions come from:

Avoid canned food or choose BPA-free cans (and verify the alternative lining): Choose fresh, frozen, or glass-packaged foods instead of canned where practical. Many brands now offer BPA-free can linings, though some use acrylic or polyester alternatives whose long-term safety profile is less studied.

Switch to glass, stainless steel, or ceramic for food storage and drinking: These materials do not leach endocrine-disrupting chemicals. Stainless steel water bottles, glass meal-prep containers, and cast iron or stainless cookware eliminate a major daily exposure route.

Never heat food in plastic: Microwaving food in plastic containers dramatically increases BPA (and other plasticizer) leaching. Use glass or ceramic in the microwave exclusively.

Minimize receipt handling: Decline paper receipts when possible or ask for digital copies. If you handle receipts regularly, wash hands before eating. Avoid using hand sanitizer immediately before handling thermal paper.

Choose fresh or frozen produce over canned: Especially acidic vegetables and tomato-based products, which leach more from can linings.

See our Phthalates page for information on another major class of plastic-associated endocrine disruptors, and our Microplastics page for the broader picture of plastic chemical exposure.

Evidence Review

Rochester (2013) — Reproductive Toxicology [PMID 23994667]

This comprehensive narrative review synthesized 91 human epidemiological studies published through 2012 linking BPA exposure to human health outcomes. Rochester organized findings by life stage and organ system. Reproductive effects were the most extensively documented: in women, BPA exposure was associated with PCOS, endometriosis, altered ovarian reserve, and adverse IVF outcomes; in men, with reduced sperm quality, altered semen parameters, and elevated FSH. Metabolic associations were strong: studies consistently found higher urinary BPA associated with increased type 2 diabetes prevalence (OR approximately 1.4–2.4 depending on study) and cardiovascular disease. Importantly, most associations persisted after controlling for confounders including BMI, age, and socioeconomic status. The author noted that 53 of the 91 studies had been published in the single year prior to the review, reflecting rapid accumulation of evidence. Key limitation: as a cross-sectional literature, reverse causation (sicker people excreting more BPA) cannot be fully excluded, though the biological plausibility and consistency across studies strengthens the causal interpretation.

Vom Saal and Vandenberg (2021) — Endocrinology [PMID 33516155]

This invited update by two of the field's most prominent researchers argues that the evidence of harm from BPA has reached the threshold of "overwhelming" and that regulatory agencies have lagged behind the science. The authors highlight several mechanisms of concern: non-monotonic dose-response curves (effects at low concentrations not predicted by high-dose extrapolation), epigenetic effects (BPA alters DNA methylation patterns, with effects that may persist across generations), and windows of vulnerability (the fetal and neonatal periods being particularly sensitive). They note that the acceptable daily intake (ADI) set by the European Food Safety Authority (EFSA) and the FDA's tolerable daily intake (TDI) were derived from decades-old rodent studies examining only traditional toxicological endpoints (body weight, organ weights), not hormonal endpoints. Studies using endocrine-specific endpoints find effects at exposures 100–1,000-fold below the regulatory thresholds. The paper calls for a complete reassessment of BPA risk standards using modern endocrinology frameworks.

Rochester and Bolden (2015) — Environmental Health Perspectives [PMID 25775505]

This systematic review addressed the critical question of whether BPA substitutes are safer. The authors searched for all available studies on the hormonal activity of BPS and BPF and identified 32 qualifying studies (25 in vitro, 7 in vivo). The findings were consistent across study types: both BPS and BPF demonstrated estrogenic activity comparable to BPA, with EC50 values (concentration producing half-maximum effect) in the same order of magnitude. BPS showed anti-androgenic activity equivalent to BPA in several assays; BPF also demonstrated anti-androgenic effects. In vivo studies in fish, rodents, and insects confirmed estrogenic and reproductive effects at environmentally relevant concentrations. The authors concluded that the widespread use of BPS and BPF as BPA substitutes was not supported by safety evidence and that "BPA-free" labeling is misleading consumers. They noted that BPS is even more environmentally stable than BPA, raising concerns about environmental accumulation.

Vandenberg et al. (2012) — Ciencia e Saude Coletiva [PMID 22267036]

This biomonitoring review synthesized over 80 human biomonitoring studies measuring BPA in human tissues, urine, blood, breast milk, and amniotic fluid. Conjugated BPA (the metabolized form) was detected in the urine of the vast majority of individuals tested across multiple countries, with median urinary concentrations in the nanograms per milliliter range. Crucially, unconjugated (biologically active) BPA was consistently detected in blood at concentrations predicted to produce estrogenic effects in cell-based assays, challenging the prior assumption that BPA is rapidly and completely metabolized before entering systemic circulation. The persistence of unconjugated BPA in blood implies that internal exposure is higher than previously estimated from urine metabolite data alone. The review established that human exposure to BPA is essentially ubiquitous in industrialized populations, making it one of the most widespread synthetic chemical exposures in modern life.

References

Bisphenol A and human health: a review of the literatureRochester JR. Reproductive Toxicology, 2013. PubMed 23994667 →
Update on the Health Effects of Bisphenol A: Overwhelming Evidence of HarmVom Saal FS, Vandenberg LN. Endocrinology, 2021. PubMed 33516155 →
Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A SubstitutesRochester JR, Bolden AL. Environmental Health Perspectives, 2015. PubMed 25775505 →
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol AVandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Ciencia e Saude Coletiva, 2012. PubMed 22267036 →
Bisphenol A (BPA): Use in Food Contact ApplicationU.S. Food and Drug Administration. U.S. FDA, 2023. Source →